Merck Again In Canadian Class Action Lawsuit Over Osteoporosis Drug Fosamax
A class action lawsuit has been filed in Canada against Merck Frosst Canada regarding its osteoporosis
drug Fosamax.
The lawsuit alleges that Merck failed to adequately warn patients and physicians that Fosamax has been associated with an increased risk of developing Osteonecrosis of the jaw, also known as “jaw death” which can be extremely painful and can cause jaw bones to rot and die.
Filed under Class Action, General Law
You may also like to read
- Merck Faces Second Class Action Lawsuit Over The Pain Killer Case
- Pharmaceutical giant Merck decided to pay lawsuit settlement agreement
- Merck To Appeal Vioxx Class Action Lawsuit Scope Expansion
- Israeli Citizens File Class Action Against Vioxx
- Mistrial in Vioxx Class Action Lawsuit in Houston
- Vioxx Lawsuit Update - Consumer Perspective
- Double Setback in Vioxx Class Action Lawsuit
- Analysis of Class Action Law Suits Against Merck for Vioxx
- Vioxx Formula is Key To The Trial
- Canadian Internet Policy and Public Interest Clinic Objects to Sony Class Action Lawsuit Settlement
